Survivin-Targeted Immunotherapy Drives Robust Polyfunctional T Cell Generation and Differentiation in Advanced Ovarian Cancer Patients

OncoImmunology - United States
doi 10.1080/2162402x.2015.1026529
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

IL15 and T-Cell Stemness in T-Cell-Based Cancer Immunotherapy

Cancer Research
Cancer ResearchOncology
2015English

Sipuleucel-T: Immunotherapy for Advanced Prostate Cancer

Research and Reports in Urology
Urology
2011English

Survivin Promotes Piperlongumine Resistance in Ovarian Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

Generation of Potent T-Cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors

Cancer immunology research
Cancer ResearchImmunology
2015English

Mesothelin Targeted Cancer Immunotherapy

European Journal of Cancer
Cancer ResearchOncology
2008English

Allogeneic Cell‑based Immunotherapy Combined With Chemotherapy and Targeted Therapy in Advanced Pancreatic Cancer With Metastases: A Case Report

Oncology Letters
Cancer ResearchOncology
2014English

Letter: Programmed Cell Death Protein-1-Targeted Immunotherapy for Advanced Hepatocellular Carcinoma

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Immunotherapy With Checkpoint Inhibitors in Patients With Ovarian Cancer: Still Promising?

Cancer
Cancer ResearchOncology
2019English

Chimeric NKG2D Receptor-Bearing T Cells as Immunotherapy for Ovarian Cancer

Cancer Research
Cancer ResearchOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy